Compare VGZ & PMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | VGZ | PMI |
|---|---|---|
| Founded | 1983 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 229.7M | 202.7M |
| IPO Year | N/A | 2025 |
| Metric | VGZ | PMI |
|---|---|---|
| Price | $1.99 | $2.01 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 250.6K |
| Earning Date | 11-12-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,767,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 8.81 |
| 52 Week Low | $0.47 | $1.90 |
| 52 Week High | $2.46 | $13.68 |
| Indicator | VGZ | PMI |
|---|---|---|
| Relative Strength Index (RSI) | 62.20 | N/A |
| Support Level | $1.89 | N/A |
| Resistance Level | $2.03 | N/A |
| Average True Range (ATR) | 0.12 | 0.00 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 90.21 | 0.00 |
Vista Gold Corp is a gold mining company. It is engaged in the evaluation, acquisition, exploration, and advancement of gold exploration and potential development projects. The company evaluate, acquire, explore and advance gold exploration and potential development projects for gold production or value adding strategic transactions. The Company has one reportable segment: Australia. The Australia segment conducts exploration, development, care and maintenance activities at Vista's asset, the Mt Todd gold project in Northern Territory, Australia.
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing an implantable Total Artificial Heart. It is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including TAH. The TAH is an implantable system designed to assume the full function of a failed human heart in patients suffering from advanced heart failure.